Shom Health Care

Polymos (Polymyxin B Sulphate) Injection is a potent antibiotic formulation indicated for the treatment of serious Gram-negative bacterial infections, particularly those caused by multidrug-resistant organisms where other antibiotics may be ineffective. Polymyxin B acts by disrupting the bacterial cell membrane, leading to rapid bactericidal activity, making it an important therapeutic option in critical care settings for infections such as septicemia, hospital-acquired pneumonia, urinary tract infections, and other severe systemic infections caused by susceptible strains. The product is manufactured by Oscar Remedies and is distributed exclusively by Shom Healthcare, ensuring dependable supply, quality-assured handling, and streamlined availability to hospitals and healthcare institutions. With its targeted action against resistant pathogens and controlled administration under strict medical supervision, Polymos serves as a vital addition to antimicrobial stewardship programs in intensive care and specialty treatment environments.

INTRONUM 2G by Welcure Remedies is a premium-quality Aztreonam 2 g Injection, a potent monobactam antibiotic used for the treatment of serious Gram-negative bacterial infections. Manufactured in a WHO GMP-certified facility, INTRONUM 2G ensures high purity, safety, and consistent therapeutic efficacy, making it ideal for hospital and critical care use.

• Aztreonam 2 g Injection: Highly effective against severe Gram-negative infections including multi-drug resistant strains
• WHO GMP Manufactured: Ensures international quality and regulatory compliance
• Hospital-Grade Formulation: Suitable for ICU, inpatient, and emergency care
• Complete Documentation: Supplied with COA, Manufacturing License, MSDS, FSC, and WHO-GMP certificate
• Reliable & Consistent Performance: Trusted by healthcare professionals for severe infections

• Severe Gram-negative bacterial infections
• Urinary tract infections (UTIs)
• Respiratory tract infections
• Septicemia
• Skin and soft tissue infections
• Hospital-acquired infections (HAI)

Aztreonam works by inhibiting bacterial cell wall synthesis in Gram-negative organisms, leading to bacterial cell death. Its unique monobactam structure provides potent activity while minimizing cross-reactivity with other β-lactam antibiotics.

INTRONUM 2G Injection should be administered under strict medical supervision, typically via intravenous infusion. Dosage depends on infection type, severity, and patient renal function.

• Manufactured in a WHO GMP-certified facility
• Supported with COA, COPP, MSDS, FSC, WHO-GMP & Manufacturing License
• Suitable for global tenders and export markets

• Ensures high-quality, safe, and effective Aztreonam formulation
• WHO GMP-certified with complete regulatory documentation
• Bulk availability for hospitals, distributors, and healthcare providers
• Ideal for export-ready, hospital-grade antibiotic solutions

Order INTRONUM 2G Aztreonam Injection on IndiaMART for a WHO GMP-certified, hospital-grade solutionwith all authentic documents and certifications.

Amphotericin B is a powerful antifungal medication used to treat severe, potentially life-threatening systemic fungal infections and some parasitic infections, such as leishmaniasis. It is often considered a "gold standard" due to its broad spectrum and low resistance rates, although its use is limited by significant toxicity.

RYXTIM 4.5 MIU Injection – Colistimethate Sodium 4.5 MIU | Manufactured by Systole Remedies | Distributed by Shom Healthcare (ISO 9001 Certified)

RYXTIM 4.5 MIU Injection is a premium-quality formulation of Colistimethate Sodium 4.5 MIU, a potent polymyxin antibiotic used for the treatment of severe and multidrug-resistant (MDR) Gram-negative bacterial infections. Manufactured by Systole Remedies and distributed by Shom Healthcare (ISO 9001 certified), RYXTIM ensures reliable quality, safety, and consistency for hospital and clinical use.

Designed for critical care settings, RYXTIM 4.5 MIU is considered a last-line antibiotic for managing life-threatening infections where conventional antibiotics are ineffective.

Key Features and Benefits:

Colistimethate Sodium 4.5 MIU: High-potency antibiotic for MDR infections

Effective against resistant Gram-negative bacteria

Critical care essential: Widely used in ICU settings

Reliable manufacturing: Produced by Systole Remedies

ISO 9001 certified distribution: Assured quality and supply (Shom Healthcare)

Export-ready documentation available: COA, COPP, MSDS & Manufacturing License

Hospital-grade formulation: Suitable for severe infections

Therapeutic Indications: RYXTIM 4.5 MIU (Colistimethate Sodium) is indicated for:

Ventilator-associated pneumonia (VAP)

Hospital-acquired pneumonia (HAP)

Sepsis and bloodstream infections

Complicated urinary tract infections

Intra-abdominal infections

Infections caused by Acinetobacter, Pseudomonas, and Klebsiella species

Mechanism of Action: Colistimethate Sodium disrupts the bacterial cell membrane of Gram-negative organisms, leading to leakage of cellular contents and rapid bacterial cell death. It is highly effective against multidrug-resistant strains.

Dosage and Administration: RYXTIM 4.5 MIU Injection should be administered under strict medical supervision. It can be given via intravenous (IV), intramuscular (IM), or inhalation routes depending on the clinical condition.

Quality Assurance & Compliance:

Manufactured by Systole Remedies

Distributed by Shom Healthcare (ISO 9001 certified)

Supported with COA, COPP, MSDS & Manufacturing License

Suitable for hospital supply and export markets

Storage Instructions: Store in a cool, dry place below recommended temperature. Protect from light and moisture.

---

Why Choose RYXTIM 4.5 MIU by Systole Remedies & Shom Healthcare?
With its strong efficacy against multidrug-resistant infections, reliable manufacturing, and ISO-certified distribution, RYXTIM 4.5 MIU is a dependable solution for critical care and hospital use.